Hormone Refractory Prostate Cancer (HRPCA) or Castrate-Resistant Prostate Cancer (CRPC), a type of prostate cancer that typically recurs after having hormonal therapy, is now under the spotlight in prostate cancer market. Due to the high unmet clinical need associated with limited survival periods, intensifying HRPCA prevalence and fast-emerging treatment modifications, the global HRPCA market is poised to witness an unprecedented growth.
In 2017, the global Hormone Refractory Prostate Cancer market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2018-2025.
This report focuses on the global Hormone Refractory Prostate Cancer status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Hormone Refractory Prostate Cancer development in United States, Europe and China.
The key players covered in this study
Astellas Inc
Sanofi S.A
Dendreon Corporation, Bayer AG
Johnson & Johnson
...
Market segment by Type, the product can be split into
Chemotherapy
Hormonal Therapy
Immunotherapy
Radiation Therapy
Surgery
Market segment by Application, split into
Hospitals
Ambulatory Surgical Centers
Specialty Clinics
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Hormone Refractory Prostate Cancer status, future forecast, growth opportunity, key market and key players.
To present the Hormone Refractory Prostate Cancer development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Hormone Refractory Prostate Cancer are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Hormone Refractory Prostate Cancer Market Size Growth Rate by Type (2013-2025)
1.4.2 Chemotherapy
1.4.3 Hormonal Therapy
1.4.4 Immunotherapy
1.4.5 Radiation Therapy
1.4.6 Surgery
1.5 Market by Application
1.5.1 Global Hormone Refractory Prostate Cancer Market Share by Application (2013-2025)
1.5.2 Hospitals
1.5.3 Ambulatory Surgical Centers
1.5.4 Specialty Clinics
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Hormone Refractory Prostate Cancer Market Size
2.2 Hormone Refractory Prostate Cancer Growth Trends by Regions
2.2.1 Hormone Refractory Prostate Cancer Market Size by Regions (2013-2025)
2.2.2 Hormone Refractory Prostate Cancer Market Share by Regions (2013-2018)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Hormone Refractory Prostate Cancer Market Size by Manufacturers
3.1.1 Global Hormone Refractory Prostate Cancer Revenue by Manufacturers (2013-2018)
3.1.2 Global Hormone Refractory Prostate Cancer Revenue Market Share by Manufacturers (2013-2018)
3.1.3 Global Hormone Refractory Prostate Cancer Market Concentration Ratio (CR5 and HHI)
3.2 Hormone Refractory Prostate Cancer Key Players Head office and Area Served
3.3 Key Players Hormone Refractory Prostate Cancer Product/Solution/Service
3.4 Date of Enter into Hormone Refractory Prostate Cancer Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Hormone Refractory Prostate Cancer Market Size by Type (2013-2018)
4.2 Global Hormone Refractory Prostate Cancer Market Size by Application (2013-2018)
5 United States
5.1 United States Hormone Refractory Prostate Cancer Market Size (2013-2018)
5.2 Hormone Refractory Prostate Cancer Key Players in United States
5.3 United States Hormone Refractory Prostate Cancer Market Size by Type
5.4 United States Hormone Refractory Prostate Cancer Market Size by Application
6 Europe
6.1 Europe Hormone Refractory Prostate Cancer Market Size (2013-2018)
6.2 Hormone Refractory Prostate Cancer Key Players in Europe
6.3 Europe Hormone Refractory Prostate Cancer Market Size by Type
6.4 Europe Hormone Refractory Prostate Cancer Market Size by Application
7 China
7.1 China Hormone Refractory Prostate Cancer Market Size (2013-2018)
7.2 Hormone Refractory Prostate Cancer Key Players in China
7.3 China Hormone Refractory Prostate Cancer Market Size by Type
7.4 China Hormone Refractory Prostate Cancer Market Size by Application
8 Japan
8.1 Japan Hormone Refractory Prostate Cancer Market Size (2013-2018)
8.2 Hormone Refractory Prostate Cancer Key Players in Japan
8.3 Japan Hormone Refractory Prostate Cancer Market Size by Type
8.4 Japan Hormone Refractory Prostate Cancer Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Hormone Refractory Prostate Cancer Market Size (2013-2018)
9.2 Hormone Refractory Prostate Cancer Key Players in Southeast Asia
9.3 Southeast Asia Hormone Refractory Prostate Cancer Market Size by Type
9.4 Southeast Asia Hormone Refractory Prostate Cancer Market Size by Application
10 India
10.1 India Hormone Refractory Prostate Cancer Market Size (2013-2018)
10.2 Hormone Refractory Prostate Cancer Key Players in India
10.3 India Hormone Refractory Prostate Cancer Market Size by Type
10.4 India Hormone Refractory Prostate Cancer Market Size by Application
11 Central & South America
11.1 Central & South America Hormone Refractory Prostate Cancer Market Size (2013-2018)
11.2 Hormone Refractory Prostate Cancer Key Players in Central & South America
11.3 Central & South America Hormone Refractory Prostate Cancer Market Size by Type
11.4 Central & South America Hormone Refractory Prostate Cancer Market Size by Application
12 International Players Profiles
12.1 Astellas Inc
12.1.1 Astellas Inc Company Details
12.1.2 Company Description and Business Overview
12.1.3 Hormone Refractory Prostate Cancer Introduction
12.1.4 Astellas Inc Revenue in Hormone Refractory Prostate Cancer Business (2013-2018)
12.1.5 Astellas Inc Recent Development
12.2 Sanofi S.A
12.2.1 Sanofi S.A Company Details
12.2.2 Company Description and Business Overview
12.2.3 Hormone Refractory Prostate Cancer Introduction
12.2.4 Sanofi S.A Revenue in Hormone Refractory Prostate Cancer Business (2013-2018)
12.2.5 Sanofi S.A Recent Development
12.3 Dendreon Corporation, Bayer AG
12.3.1 Dendreon Corporation, Bayer AG Company Details
12.3.2 Company Description and Business Overview
12.3.3 Hormone Refractory Prostate Cancer Introduction
12.3.4 Dendreon Corporation, Bayer AG Revenue in Hormone Refractory Prostate Cancer Business (2013-2018)
12.3.5 Dendreon Corporation, Bayer AG Recent Development
12.4 Johnson & Johnson
12.4.1 Johnson & Johnson Company Details
12.4.2 Company Description and Business Overview
12.4.3 Hormone Refractory Prostate Cancer Introduction
12.4.4 Johnson & Johnson Revenue in Hormone Refractory Prostate Cancer Business (2013-2018)
12.4.5 Johnson & Johnson Recent Development
13 Market Forecast 2018-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2018-2025)
13.10 Market Size Forecast by Application (2018-2025)
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
List of Tables and Figures
Table Hormone Refractory Prostate Cancer Key Market Segments
Table Key Players Hormone Refractory Prostate Cancer Covered
Table Global Hormone Refractory Prostate Cancer Market Size Growth Rate by Type 2013-2025 (Million US$)
Figure Global Hormone Refractory Prostate Cancer Market Size Market Share by Type 2013-2025
Figure Chemotherapy Figures
Table Key Players of Chemotherapy
Figure Hormonal Therapy Figures
Table Key Players of Hormonal Therapy
Figure Immunotherapy Figures
Table Key Players of Immunotherapy
Figure Radiation Therapy Figures
Table Key Players of Radiation Therapy
Figure Surgery Figures
Table Key Players of Surgery
Table Global Hormone Refractory Prostate Cancer Market Size Growth by Application 2013-2025 (Million US$)
Figure Hospitals Case Studies
Figure Ambulatory Surgical Centers Case Studies
Figure Specialty Clinics Case Studies
Figure Hormone Refractory Prostate Cancer Report Years Considered
Table Global Hormone Refractory Prostate Cancer Market Size 2013-2025 (Million US$)
Figure Global Hormone Refractory Prostate Cancer Market Size and Growth Rate 2013-2025 (Million US$)
Table Global Hormone Refractory Prostate Cancer Market Size by Regions 2013-2025 (Million US$)
Table Global Hormone Refractory Prostate Cancer Market Size by Regions 2013-2018 (Million US$)
Table Global Hormone Refractory Prostate Cancer Market Share by Regions 2013-2018
Figure Global Hormone Refractory Prostate Cancer Market Share by Regions 2013-2018
Figure Global Hormone Refractory Prostate Cancer Market Share by Regions 2018
Table Market Top Trends
Table Global Hormone Refractory Prostate Cancer Revenue by Manufacturers (2013-2018) (Million US$)
Table Global Hormone Refractory Prostate Cancer Market Share by Manufacturers (2013-2018)
Figure Global Hormone Refractory Prostate Cancer Market Share by Manufacturers in 2018
Table Global Hormone Refractory Prostate Cancer Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Hormone Refractory Prostate Cancer Product/Solution/Service
Table Date of Enter into Hormone Refractory Prostate Cancer Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Hormone Refractory Prostate Cancer Market Size by Type (2013-2018) (Million US$)
Table Global Hormone Refractory Prostate Cancer Market Size Share by Type (2013-2018)
Figure Global Hormone Refractory Prostate Cancer Market Size Market Share by Type (2013-2018)
Table Global Hormone Refractory Prostate Cancer Market Size by Application (2013-2018) (Million US$)
Table Global Hormone Refractory Prostate Cancer Market Size Share by Application (2013-2018)
Figure Global Hormone Refractory Prostate Cancer Market Size Market Share by Application (2013-2018)
Figure Global Hormone Refractory Prostate Cancer Revenue Market Share by Application in 2017
Figure United States Hormone Refractory Prostate Cancer Market Size 2013-2018 (Million US$)
Table United States Key Players Hormone Refractory Prostate Cancer Revenue (2017-2018) (Million US$)
Table United States Key Players Hormone Refractory Prostate Cancer Market Share (2017-2018)
Table United States Hormone Refractory Prostate Cancer Market Size by Type (2013-2018) (Million US$)
Table United States Hormone Refractory Prostate Cancer Market Share by Type (2013-2018)
Table United States Hormone Refractory Prostate Cancer Market Size by Application (2013-2018) (Million US$)
Table United States Hormone Refractory Prostate Cancer Market Share by Application (2013-2018)
Figure Europe Hormone Refractory Prostate Cancer Market Size 2013-2018 (Million US$)
Table Europe Key Players Hormone Refractory Prostate Cancer Revenue (2017-2018) (Million US$)
Table Europe Key Players Hormone Refractory Prostate Cancer Market Share (2017-2018)
Table Europe Hormone Refractory Prostate Cancer Market Size by Type (2013-2018) (Million US$)
Table Europe Hormone Refractory Prostate Cancer Market Share by Type (2013-2018)
Table Europe Hormone Refractory Prostate Cancer Market Size by Application (2013-2018) (Million US$)
Table Europe Hormone Refractory Prostate Cancer Market Share by Application (2013-2018)
Figure China Hormone Refractory Prostate Cancer Market Size 2013-2018 (Million US$)
Table China Key Players Hormone Refractory Prostate Cancer Revenue (2017-2018) (Million US$)
Table China Key Players Hormone Refractory Prostate Cancer Market Share (2017-2018)
Table China Hormone Refractory Prostate Cancer Market Size by Type (2013-2018) (Million US$)
Table China Hormone Refractory Prostate Cancer Market Share by Type (2013-2018)
Table China Hormone Refractory Prostate Cancer Market Size by Application (2013-2018) (Million US$)
Table China Hormone Refractory Prostate Cancer Market Share by Application (2013-2018)
Figure Japan Hormone Refractory Prostate Cancer Market Size 2013-2018 (Million US$)
Table Japan Key Players Hormone Refractory Prostate Cancer Revenue (2017-2018) (Million US$)
Table Japan Key Players Hormone Refractory Prostate Cancer Market Share (2017-2018)
Table Japan Hormone Refractory Prostate Cancer Market Size by Type (2013-2018) (Million US$)
Table Japan Hormone Refractory Prostate Cancer Market Share by Type (2013-2018)
Table Japan Hormone Refractory Prostate Cancer Market Size by Application (2013-2018) (Million US$)
Table Japan Hormone Refractory Prostate Cancer Market Share by Application (2013-2018)
Figure Southeast Asia Hormone Refractory Prostate Cancer Market Size 2013-2018 (Million US$)
Table Southeast Asia Key Players Hormone Refractory Prostate Cancer Revenue (2017-2018) (Million US$)
Table Southeast Asia Key Players Hormone Refractory Prostate Cancer Market Share (2017-2018)
Table Southeast Asia Hormone Refractory Prostate Cancer Market Size by Type (2013-2018) (Million US$)
Table Southeast Asia Hormone Refractory Prostate Cancer Market Share by Type (2013-2018)
Table Southeast Asia Hormone Refractory Prostate Cancer Market Size by Application (2013-2018) (Million US$)
Table Southeast Asia Hormone Refractory Prostate Cancer Market Share by Application (2013-2018)
Figure India Hormone Refractory Prostate Cancer Market Size 2013-2018 (Million US$)
Table India Key Players Hormone Refractory Prostate Cancer Revenue (2017-2018) (Million US$)
Table India Key Players Hormone Refractory Prostate Cancer Market Share (2017-2018)
Table India Hormone Refractory Prostate Cancer Market Size by Type (2013-2018) (Million US$)
Table India Hormone Refractory Prostate Cancer Market Share by Type (2013-2018)
Table India Hormone Refractory Prostate Cancer Market Size by Application (2013-2018) (Million US$)
Table India Hormone Refractory Prostate Cancer Market Share by Application (2013-2018)
Figure Central & South America Hormone Refractory Prostate Cancer Market Size 2013-2018 (Million US$)
Table Central & South America Key Players Hormone Refractory Prostate Cancer Revenue (2017-2018) (Million US$)
Table Central & South America Key Players Hormone Refractory Prostate Cancer Market Share (2017-2018)
Table Central & South America Hormone Refractory Prostate Cancer Market Size by Type (2013-2018) (Million US$)
Table Central & South America Hormone Refractory Prostate Cancer Market Share by Type (2013-2018)
Table Central & South America Hormone Refractory Prostate Cancer Market Size by Application (2013-2018) (Million US$)
Table Central & South America Hormone Refractory Prostate Cancer Market Share by Application (2013-2018)
Table Astellas Inc Company Details
Table Astellas Inc Revenue in Hormone Refractory Prostate Cancer Business (2013-2018) (Million US$)
Figure Astellas Inc Revenue Growth Rate in Hormone Refractory Prostate Cancer Business (2013-2018)
Table Astellas Inc Recent Development
Table Sanofi S.A Company Details
Table Sanofi S.A Revenue in Hormone Refractory Prostate Cancer Business (2013-2018)(Million US$)
Figure Sanofi S.A Revenue Growth Rate in Hormone Refractory Prostate Cancer Business (2013-2018)
Table Sanofi S.A Recent Development
Table Dendreon Corporation, Bayer AG Company Details
Table Dendreon Corporation, Bayer AG Revenue in Hormone Refractory Prostate Cancer Business (2013-2018)(Million US$)
Figure Dendreon Corporation, Bayer AG Revenue Growth Rate in Hormone Refractory Prostate Cancer Business (2013-2018)
Table Dendreon Corporation, Bayer AG Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Revenue in Hormone Refractory Prostate Cancer Business (2013-2018)(Million US$)
Figure Johnson & Johnson Revenue Growth Rate in Hormone Refractory Prostate Cancer Business (2013-2018)
Table Johnson & Johnson Recent Development
Table Global Hormone Refractory Prostate Cancer Market Size by Regions (Million US$) 2018-2025
Figure Global Hormone Refractory Prostate Cancer Market Size Share by Regions (2018-2025)
Figure Global Hormone Refractory Prostate Cancer Market Size Share by Regions in 2025
Figure United States Hormone Refractory Prostate Cancer Market Size Forecast (2018-2025)(Million USD)
Figure Europe Hormone Refractory Prostate Cancer Market Size Forecast (2018-2025)(Million USD)
Figure China Hormone Refractory Prostate Cancer Market Size Forecast (2018-2025)(Million USD)
Figure Japan Hormone Refractory Prostate Cancer Market Size Forecast (2018-2025)(Million USD)
Figure Southeast Asia Hormone Refractory Prostate Cancer Market Size Forecast (2018-2025)(Million USD)
Figure India Hormone Refractory Prostate Cancer Market Size Forecast (2018-2025)(Million USD)
Figure Central & South America Hormone Refractory Prostate Cancer Market Size Forecast (2018-2025)(Million USD)
Table Global Hormone Refractory Prostate Cancer Market Size by Product (2018-2025) (Million US$)
Figure Global Hormone Refractory Prostate Cancer Market Size by Product (2018-2025)
Figure Global Hormone Refractory Prostate Cancer Market Size by Product in 2025
Table Global Hormone Refractory Prostate Cancer Market Size by Application (2018-2025) (Million US$)
Figure Global Hormone Refractory Prostate Cancer Market Size by Application (2018-2025)
Figure Global Hormone Refractory Prostate Cancer Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
